| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10218644 | Clinical Microbiology and Infection | 2018 | 21 Pages |
Abstract
The developed CRISPR-Cas9-based genome engineering tool will facilitate functional genomic studies in C. difficile as well as the elucidation of mechanisms related to host-bacteria interaction and pathogenesis of CDI. This will be highly beneficial for the development of innovative strategies for CDI diagnostics and therapies.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
S. Wang, W. Hong, S. Dong, Z.-T. Zhang, J. Zhang, L. Wang, Y. Wang,